How the COVID-19 vaccines are assessed
Medsafe is New Zealand’s medicines safety authority. It evaluates applications for all new medicines, including vaccines, to make sure they meet international standards and local requirements.
COVID-19 vaccines are being held to the same standards and requirements as all vaccines before they get full approval.
Medsafe will only recommend a medicine is approved to use in New Zealand if it meets these standards. If approval is granted, it will either be full approval under section 20 of the Medicines Act 1981, or provisional approval under section 23.